AN ANALYSIS OF FETAL HEMOGLOBIN VARIATION IN SICKLE-CELL DISEASE - THE RELATIVE CONTRIBUTIONS OF THE X-LINKED FACTOR, BETA-GLOBIN HAPLOTYPES, ALPHA-GLOBIN GENE NUMBER, GENDER, AND AGE

被引:96
作者
CHANG, YC
SMITH, KD
MOORE, RD
SERJEANT, GR
DOVER, GJ
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD USA
[3] KENNEDY KRIEGER INST, BALTIMORE, MD USA
[4] UNIV W INDIES, CTR SICKLE CELL, KINGSTON, JAMAICA
关键词
D O I
10.1182/blood.V85.4.1111.bloodjournal8541111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Five factors have been shown to influence the 20-fold variation of fetal hemoglobin (Hb F) levels in sickle cell anemia (SS): age, sex, the alpha-globin gene number, beta-globin haplotypes, and an X-linked locus that regulates the production of Hb F-containing erythrocytes (F cells), ie, the F-cell production (FCP) locus. To determine the relative importance of these factors, we studied 257 Jamaican SS subjects from a Cohort group identified by newborn screening and from a Sib Pair study. Linear regression analyses showed that each variable, when analyzed alone, had a significant association with Hb F levels (P < .05). Multiple regression analysis, including all variables, showed that the FCP locus is the strongest predictor, accounting for 40% of Hb F variation, beta-Globin haplotypes, alpha-globin genes, and age accounted for less than 10% of the variation. The association between the beta-globin haplotypes and Hb F levels becomes apparent if the influence of the FCP locus is removed by analyzing only individuals with the same FCP phenotype, Thus, the FCP locus is the most important factor identified to date in determining Hb F levels. The variation within each FCP phenotype is modulated by factors associated with the three common beta-globin haplotypes and other as yet unidentified factor(s). (C) 1995 by The American Society of Hematology.
引用
收藏
页码:1111 / 1117
页数:7
相关论文
共 38 条
[31]  
SERJEANT BE, 1974, CLIN CHEM, V20, P666
[32]  
SERJEANT GR, 1975, CLIN HAEMATOL, V4, P109
[33]   THE DEVELOPMENT OF HEMATOLOGICAL-CHANGES IN HOMOZYGOUS SICKLE-CELL DISEASE - A COHORT STUDY FROM BIRTH TO 6 YEARS [J].
SERJEANT, GR ;
GRANDISON, Y ;
LOWRIE, Y ;
MASON, K ;
PHILLIPS, J ;
SERJEANT, BE ;
VAIDYA, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 48 (04) :533-543
[34]   GENETIC-REGULATION OF GAMMA-GENE EXPRESSION - STUDY OF THE INTERACTION OF BETA-THALASSEMIA WITH HETEROCELLULAR HPFH [J].
SOUMMER, AM ;
TESTA, U ;
DUJARDIN, P ;
GUERRASIO, A ;
HENRI, A ;
GAZAIX, M ;
RIOU, J ;
ROCHANT, H ;
BEUZARD, Y ;
ROSA, J .
HUMAN GENETICS, 1981, 57 (04) :371-375
[35]  
STAMATOYANNOPOU.G, 1988, MOL BASIS BLOOD DISE, P66
[36]   MILD SICKLE-CELL DISEASE - CLINICAL AND LABORATORY STUDIES [J].
STEINBERG, MH ;
DREILING, BJ ;
MORRISON, FS ;
NECHELES, TF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 224 (03) :317-321
[37]  
THEIN SL, 1994, AM J HUM GENET, V54, P214
[38]   THE MAJOR HUMAN ERYTHROID DNA-BINDING PROTEIN (GF-1) - PRIMARY SEQUENCE AND LOCALIZATION OF THE GENE TO THE X-CHROMOSOME [J].
ZON, LI ;
TSAI, SF ;
BURGESS, S ;
MATSUDAIRA, P ;
BRUNS, GAP ;
ORKIN, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :668-672